[{"Assets_0_Q1_USD":"37624300000.0","CIK":"59478","CommonStockDividendsPerShareCashPaid_1_Q1_USD":"0.52","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.1","EarningsPerShareDiluted_1_Q1_USD":"-0.1","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q1_USD":"72700000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"339900000.0","NetIncomeLoss_1_Q1_USD":"-110800000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_1_Q1_USD":"547400000.0","RevenuesConverted_1_Q1_USD":"5228300000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"14103700000.0","StockholdersEquity_0_Q1_USD":"14031000000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"1056300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"1056300000.0","filed":"20170501","footnote":null,"form":"10-Q","fp":"Q1","fy":"2017.0","name":"LILLY ELI & CO","period":"20170331","qtrs":"0","uom":"USD"}]